INBX
#2048
Inhibrx Biosciences, Inc. - Common Stock
124.6 6 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.61%
Changement Mensuel
+52.28%
Evolution sur 6 mois
+65.07%
Changement Annuel
+54.70%
Clôture Précédente
126.7 0
Open
124.6 6
Low
124.6 6
High
124.6 6
Volume
31
Financials
- Market Capitalization 1.83 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-10.67
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2032 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -17.51% | +10.61% | +211.97% | 1.90 B USD | ||
| 2040 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +100.70% | 1.86 B USD | ||
| 2060 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.10 USD | +4.20% | +0.90% | +5.73% | +24.69% | 1.79 B USD | ||
| 2067 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -2.06% | -4.86% | +9.90% | -29.15% | 1.78 B USD |